Navigation Links
Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares,Favorably to Drug-Eluting Stents

Risk of Late Thrombosis is Minimized with Genous Stent

BARCELONA, Spain, May 23, 2007 /PRNewswire/ -- The efficacy of OrbusNeich's Genous(TM) Bio-engineered R stent compares favorably to that of drug-eluting stents, while the risk of late thrombosis is minimized with the Genous stent, according to an interim analysis of post-marketing data presented today by Robbert de Winter, M.D., Ph.D., at EuroPCR 2007 in Barcelona, Spain.

Collected from more than 120 sites in 29 countries, follow-up data for patients who received at least one Genous Bio-engineered R stent show:

    -- For 2,175 patients at 30 days, the target lesion revascularization

       (TLR) rate was 0.05%, the major adverse cardiac events (MACE) rate was

       1.61%, and the sub-acute thrombosis (SAT) rate was 0.37%


    -- For 1,039 patients at six months, the TLR rate was 2.89%, the MACE rate

       was 5.87%, and the thrombosis rate was 0.88%

"The real-world data speak to the promise of OrbusNeich's innovative pro- healing approach with Genous, especially when we compare the findings to those of the drug-eluting stent registries," said de Winter, a co-principal investigator of the study and director of the catheterization laboratory at the Academic Medical Center in Amsterdam. "The importance of this interim data is that Genous appears to be as effective as drug-eluting stents with only the need for minimal dual-antiplatelet therapy, which is safer for patients and less expensive."

OrbusNeich's e-HEALING is a multi-center, worldwide prospective registry of patients treated with the Genous Bio-engineered R stent in accordance with the instructions for use. The protocol recommends that patients receive two weeks of statin treatment prior to the procedure and one month of clopidogrel treatment after the procedure. Clinical follow-up takes place at 30 days, six months and 12 months. The primary outcome of the reg
'"/>




Page: 1 2 3

Related medicine technology :

1. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
4. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
5. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
6. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
7. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
8. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
9. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care
10. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
11. Studies Show Efficacy and Safety of Alexions Soliris in Broad Population of PNH Patients
Post Your Comments:
(Date:12/19/2014)... Dec. 19, 2014 Breckenridge Pharmaceutical, Inc. announced ... with MSN Laboratories Pvt. Ltd. ( Hyderabad, India ... commercialize several new ANDAs.  Under the terms of the ... exclusively to Breckenridge for the U.S. market, and Breckenridge ... Breckenridge and MSN have agreed to develop an oral ...
(Date:12/19/2014)... -- Monarch America Inc. (OTCQB: CANK) ("Monarch America" or the ... this review of the Company,s recent achievements and strategic ... this past year, we achieved many of our early ... say that Monarch America is in a stronger and ... stated Eric Hagen , CEO of Monarch America ...
(Date:12/19/2014)... Dec. 18, 2014 Research and Markets ... of the "Micro Market Monitor: North American ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... progressing steadily, which has resulted in fueling the ... The main purpose of these dermatology devices is ...
Breaking Medicine Technology:Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3
... of a primary biliary cirrhosis patient,has the biomarker ... Mayo Clinic,researchers have found that first-degree relatives ... cirrhosis (PBC) are,more likely to have the biomarker ... new information, physicians could screen and assess first-degree,relatives ...
... (Nasdaq: PPHM ), a clinical stage biopharmaceutical,company ... and,hepatitis C virus (HCV) infection, today announced that ... Controller General of India (DCGI) for an,open label ... in combination,with the chemotherapy drugs paclitaxel and carboplatin ...
Cached Medicine Technology:New Research May Lead to Earlier Diagnosis and Treatment of Primary Biliary Cirrhosis in Families 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 4
(Date:12/22/2014)... NY (PRWEB) December 22, 2014 ... a federal panel of judges has granted a request ... in the U.S. District Court, Eastern District of Louisiana. ... an order on December 12 to transfer over 50 ... 22 districts to the Louisiana court for consolidation under ...
(Date:12/22/2014)... FL (PRWEB) December 22, 2014 Christmas is ... Beauty® has a fast and easy solution that will please: ... cards can be purchased from from $25 up to $350," ... offer 100% customer satisfaction and a wide array of skin ... no fees and no expiration dates. , Gift delivery ...
(Date:12/22/2014)... 22, 2014 The NLN’s ... development programs this month. Faculty have been selected ... nurse educators fast-tracked for administrative leadership roles within ... Program for Simulation Educators, featuring a curriculum uniquely ... nursing education. , Twenty nurse educators were ...
(Date:12/21/2014)... (PRWEB) December 22, 2014 Recently, BambooFlooringChina.com, ... durable strand woven bamboo flooring collection , and launched ... 25%. The promotion is valid until Jan. 30, 2015. ... woven bamboo is the hardest bamboo flooring available today; ... resembling that of traditional teak hardwoods. Strand woven bamboo ...
(Date:12/21/2014)... 21, 2014 When families in Coral Gables ... they call? The new answer is Lice Troopers . ... 33134, their newest treatment center will be the new go-to ... and without the use of harmful chemicals or pesticides. ... January 1, 2015. Like the company’s first clinic (located at ...
Breaking Medicine News(10 mins):Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 3Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 4Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3Health News:BambooFlooringChina.com Announced Its Durable Strand Woven Bamboo Flooring Collection 2Health News:All-Natural Florida Lice Removal Company Opens New Lice Treatment Salon In South Florida 2
... The influence of genetics increases as young women transition from ... researchers at Washington University School of Medicine in St. Louis ... girls begin to drink, genes play a larger role if ... researchers studied 3,546 female twins ages 18 to 29 to ...
... Groundbreaking Program Addresses the Nursing Shortage By Supporting,1500 ... April 23 The Robert Wood Johnson,Foundation (RWJF) ... announced today the creation of the RWJF New ... nation,s nursing shortage by,dramatically expanding the pipeline of ...
... 23 Florida,s elected leaders,received a message from ... urging Governor Charlie Crist and legislative leaders not ... of the state,s most,vulnerable citizens., Driven by ... by gurney,the petitions ask Governor Crist, Senate President ...
... HEIGHTS, Ill. Lumpectomy or breast conservation surgery is ... performed. A benefit of the surgery is that only ... can be the resulting physical appearance of the breast, ... in Aprils Plastic and Reconstructive Surgery, the official medical ...
... New Business Alliance will help to raise funds ... K2 Logistics, an industry leader,focused on single-source supply ... spirit, K2 Logistics, headquartered in Eagan, announced,today its ... of,Minnesota (PAM) Team. Also joining in the fight ...
... Endocrine Society,s 90th Annual MeetingENDO 08will be held at ... 15-18, 2008. , Reporters can register here: ... all over the world are expected to assemble for ... endocrinology. , It is the opportunity for journalists ...
Cached Medicine News:Health News:Environment key early: Genes' role expands in alcohol dependence 2Health News:Environment key early: Genes' role expands in alcohol dependence 3Health News:Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program 2Health News:Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program 3Health News:Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program 4Health News:Thousands Sign Petitions Urging Governor Crist and Legislative Leaders to Save Healthcare Coverage for 40,000 Floridians 2Health News:Thousands Sign Petitions Urging Governor Crist and Legislative Leaders to Save Healthcare Coverage for 40,000 Floridians 3Health News:Breast reconstruction advances fix distortions left by lumpectomy 2Health News:K2 Logistics & Strategic Warehousing Join The Parkinson Association of Minnesota (PAM) Team! 2Health News:K2 Logistics & Strategic Warehousing Join The Parkinson Association of Minnesota (PAM) Team! 3Health News:ENDO 08: Latest news on hormones, steroids, obesity, diabetes and more 2
The advanced optics of Frequency 55 Aspheric offer an unsurpassed level of visual quality. By focusing light to a common focal point on the back of eye, instead of a general area, the aspheric design...
The proven daily wear spherical soft contact lens....
Surevue brand contact lenses deliver exceptional overall performance in a contact lens since they're easy to use and offer great comfort....
An easy-to-fit high water content spherical soft lens manufactured using cast molding technology, and designed for use in the correction of myopia on a daily wear or extended wear basis....
Medicine Products: